“…[ 6 ] (Am J Ophthalmol, 2013), thus establishing the effectiveness of this treatment modality. [ 4 ] TransPTK, by strengthening the adhesion of the basal epithelial cells to the basement membrane, caters to the underlying pathology of RCE in the form of abnormal formation of hemidesmosomes/anchoring filaments at the basal layer of the corneal epithelium, thus yielding better outcomes.…”